IND effective following 30-day FDA review; Phase 1b trial expected to initiate in Q4 2026. SMS Cells are the only known inhaled, refrigerated, allogeneic stem cell product in active Chronic ...
Standardized Stem Cell Care Delivers Measurable, Affordable, and Life-Changing Results Across the U.S. DALLAS, Oct. 22, 2025 /PRNewswire/ -- Life Sciences Review has recognized Innovations Stem Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results